NextWave Pharmaceuticals

PharmaceuticalsSeries CCupertino, USnextwavepharma.com

Latest round

Series C

Last raised

Jan 2011

Total raised

$77M

Investors

7

About NextWave Pharmaceuticals

NextWave Pharmaceuticals Inc. is a pharmaceutical company focused on developing and commercializing innovative treatments primarily for Attention Deficit Hyperactivity Disorder (ADHD)., founded in 2005, is headquartered in Cupertino, US. The company was established to create effective ADHD treatments and has completed a total of 6 deals. In October 2012, NextWave was acquired by Pfizer Inc.NextWave Pharmaceuticals specializes in the development and commercialization of innovative pharmaceutical products aimed primarily at treating Attention Deficit Hyperactivity Disorder (ADHD). Their flagship product, Quillivant XR® (methylphenidate HCl), is a liquid central nervous system stimulant designed for consistent medication delivery throughout the day, specifically formulated for pediatric patients aged 6 and older.NextWave Pharmaceuticals generates revenue mainly through sales of its prescription medication, Quillivant XR. The revenue model relies on partnerships with healthcare providers, ensuring the medication is prescribed directly to patients. Revenue stems from direct sales to pharmacies and healthcare facilities, with pricing determined through negotiations with pharmacy benefit managers and insurance companies. As a federally controlled substance, Quillivant XR is distributed under strict regulatory guidelines, highlighting the company's focus on compliance. Future initiatives include developing new ADHD treatment options and penetrating international markets with a focus on Europe and Asia by 2024.

Who invested in NextWave Pharmaceuticals

7 investors across 3 rounds

See all investors in NextWave Pharmaceuticals

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Jan 12, 2011

    Amount

    $27M

    Investors

    Locked

  2. Series B

    Jan 31, 2007

    Amount

    $40M

    Investors

    Locked

  3. Series A

    Sep 25, 2005

    Amount

    $10M

    Investors

    Locked

Questions about NextWave Pharmaceuticals

Who invested in NextWave Pharmaceuticals?

NextWave Pharmaceuticals has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has NextWave Pharmaceuticals raised?

NextWave Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did NextWave Pharmaceuticals last raise money?

NextWave Pharmaceuticals's most recent round on record is a Series C, in Jan 2011.

What does NextWave Pharmaceuticals do?

NextWave Pharmaceuticals is a pharmaceuticals company.

Where is NextWave Pharmaceuticals headquartered?

NextWave Pharmaceuticals is headquartered in Cupertino, US.

Which VCs invest in companies like NextWave Pharmaceuticals?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at NextWave Pharmaceuticals's stage. Their profiles are linked below.

Raising like NextWave Pharmaceuticals? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.